Autoimmune Blistering Diseases Session

The Autoimmune Blistering Diseases Session will provide a comprehensive overview of autoimmune blistering diseases (AIBD), focusing on pemphigus, pemphigoid, and epidermolysis bullosa acquisita (EBA). The Autoimmune Blistering Diseases Session brings together leading experts in dermatology to discuss the clinical, pathological, genetic, and treatment aspects of these diseases, with a special focus on the global burden and unique challenges in different regions, including Africa.

Attendees will gain insights into the latest advancements in AIBD research, genetics, and treatment protocols, allowing for enhanced diagnosis and management of these complex conditions.

You can register for free by clicking on this link: https://congres.cliniquedermatologique.com/registration/

Learning Objectives

• Understand the clinical, pathological, and diagnostic features of pemphigus and pemphigoid.
• Explore the genetic background of pemphigus and its implications for personalized treatment.
• Learn about the latest treatment approaches for both pemphigus and pemphigoid.
• Gain insights into the epidemiology and treatment of autoimmune blistering diseases, with a focus on their prevalence and management in Africa.

Session Chair

• Prof. Dedee Murrell, MD DSc, Sydney, Australia

Speakers and Topics

1. Prof. Branka Marinovic, MD, Croatia – EADV President
   • Overview of Autoimmune Blistering Diseases
     • Provides a broad overview of autoimmune blistering diseases, discussing their clinical presentation, diagnosis, and global impact.
2. Prof. Eli Sprecher, MD, Israel
   • Pemphigus – Genetics
     • Explores the genetic underpinnings of pemphigus and their relevance to understanding disease mechanisms and treatment approaches.
3. Prof. Pascal Joly, MD, France
   • Pemphigus – Treatment
     • Discusses the current and emerging treatment strategies for pemphigus, including the use of biologics and other targeted therapies.
4. Prof. Dedee Murrell, MD DSc, Australia
   • Pemphigoid – Treatment
     • Explores the latest advancements in pemphigoid treatment, including corticosteroids, immunosuppressants, and novel therapies.
5. Prof. Aikaterini Patsatsi Greece /Bullous Pemphigoid: Clinical Presentation, Pathophysiology, Diagnosis
6. Prof. Frederic Caux, France   /  EBA – African link
7. Prof. Jose Mascaro jr, Spain  /  Pemphigus -clinical, Pathophysiology & Diagnosis

Discussion Session

15-minute Discussion: The session will conclude with a 15-minute interactive discussion, allowing participants to engage with the experts, ask questions, and discuss treatment challenges in managing autoimmune blistering diseases.